首页> 外文期刊>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association >Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
【24h】

Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH

机译:基于质谱的胃食管肿瘤组织中Her2的定量:与IHC和FISH的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Trastuzumab has shown a survival benefit in cases of Her2-positive gastroesophageal cancer (GEC). Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) currently determine eligibility for trastuzumab-based therapy. However, these low-throughput assays often produce discordant or equivocal results.
机译:曲妥珠单抗在Her2阳性胃食管癌(GEC)病例中显示出生存获益。免疫组织化学(IHC)和荧光原位杂交(FISH)当前确定了基于曲妥珠单抗的治疗的资格。但是,这些低通量分析通常会产生不一致或模棱两可的结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号